Journal article
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
Abstract
Coronavirus disease 2019 (COVID-19), currently a worldwide pandemic, is a viral illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The suspected contribution of thrombotic events to morbidity and mortality in COVID-19 patients has prompted a search for novel potential options for preventing COVID-19-associated thrombotic disease. In this article by the Global COVID-19 Thrombosis Collaborative Group, we describe …
Authors
Bikdeli B; Madhavan MV; Gupta A; Jimenez D; Burton JR; Der Nigoghossian C; Chuich T; Nouri SN; Dreyfus I; Driggin E
Journal
Thrombosis and Haemostasis, Vol. 120, No. 07, pp. 1004–1024
Publisher
Thieme
Publication Date
July 2020
DOI
10.1055/s-0040-1713152
ISSN
0340-6245